Literature DB >> 2513208

Heterogeneity among human mononuclear phagocytes in their secretion of lysozyme, interleukin 1 and type-beta transforming growth factor: a quantitative analysis at the single-cell level.

C E Lewis1, S P McCarthy, J Lorenzen, J O McGee.   

Abstract

Human mononuclear phagocytes have the remarkable capacity to secrete a wide range of products. The reverse hemolytic plaque assay was used to visualize and quantify the secretion of lysozyme, interleukin 1 or type-beta transforming growth factor by individual monocytes and macrophages. With this sensitive immunoassay, the release of these products by either freshly isolated monocytes, macrophages derived from monocytes in vitro, or activated peritoneal macrophages was detected in both the presence and absence of secretagogues. When coupled with immunocytochemistry for EBM/11, a monoclonal marker for human cells of the monocyte/macrophage cell lineage, functional heterogeneity was evident both in the amount of lysozyme, interleukin 1 or type-beta transforming growth factor released per cell, and in the number of EBM/11+ cells which secreted detectable levels of these products at any one time. In addition, there was a size-dependent heterogeneity among human monocytes and culture-derived macrophages in their ability to secrete interleukin 1 or lysozyme, respectively. We conclude that the secretory activity of individual mononuclear phagocytes is markedly heterogeneous.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2513208     DOI: 10.1002/eji.1830191111

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Differential effects of LPS, IFN-gamma and TNF alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity.

Authors:  C E Lewis; S P McCarthy; J Lorenzen; J O McGee
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

2.  Lipopolysaccharide induction of outward potassium current expression in human monocyte-derived macrophages: lack of correlation with secretion.

Authors:  D J Nelson; B Jow; F Jow
Journal:  J Membr Biol       Date:  1992-02       Impact factor: 1.843

3.  Heterogeneous expression of apolipoprotein-E by human macrophages.

Authors:  Nicodemus Tedla; Elias N Glaros; Ulf T Brunk; Wendy Jessup; Brett Garner
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

4.  Cytokine release by human bone marrow cells: analysis at the single cell level.

Authors:  D Rohde; C Wickenhauser; S Denecke; A Stach; J Lorenzen; M L Hansmann; J Thiele; R Fischer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Interleukin 1 is processed and released during apoptosis.

Authors:  K A Hogquist; M A Nett; E R Unanue; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression.

Authors:  C L Miller-Graziano; G Szabo; K Griffey; B Mehta; K Kodys; D Catalano
Journal:  J Clin Immunol       Date:  1991-03       Impact factor: 8.317

7.  Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.

Authors:  E Breese; C P Braegger; C J Corrigan; J A Walker-Smith; T T MacDonald
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

8.  Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage.

Authors:  Woong-Ki Kim; Yue Sun; Hien Do; Patrick Autissier; Elkan F Halpern; Michael Piatak; Jeffrey D Lifson; Tricia H Burdo; Michael S McGrath; Kenneth Williams
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

9.  Activation of peripheral blood mononuclear cells in bronchoalveolar lavage fluid from patients with sarcoidosis: visualisation of single cell activation products.

Authors:  P Pantelidis; A M Southcott; A D Cambrey; G J Laurent; R M du Bois
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.